Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Guillevin

Showing results (531-540 of 541) with videos related to

Pageof 55
Sort By:
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of primary small and medium vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of large vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Annals of the Rheumatic Diseases|August 10, 2010
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practiceM C van der Goes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesJ N Hoes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|August 9, 2011
ANCA-associated vasculitis is linked to carriage of the Z allele of α₁ antitrypsin and its polymersH Morris, M D Morgan, A M Wood, et al.
Arthritis and Rheumatism|December 14, 2004
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonistJ H Korn, M Mayes, M Matucci Cerinic, et al.
Annals of the Rheumatic Diseases|September 19, 2009
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesM C van der Goes, J W G Jacobs, M Boers, et al.
Clinical and Experimental Rheumatology|May 29, 2015
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohortsC Pagnoux, S Carette, N A Khalidi, et al.
Lupus|February 14, 2009
European consensus statement on the terminology used in the management of lupus glomerulonephritisC Gordon, D Jayne, C Pusey, et al.
Pageof 55

Showing results (531-540 of 541) with videos related to

Sort By:
Pageof 55
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of primary small and medium vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of large vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Annals of the Rheumatic Diseases|August 10, 2010
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practiceM C van der Goes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesJ N Hoes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|August 9, 2011
ANCA-associated vasculitis is linked to carriage of the Z allele of α₁ antitrypsin and its polymersH Morris, M D Morgan, A M Wood, et al.
Arthritis and Rheumatism|December 14, 2004
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonistJ H Korn, M Mayes, M Matucci Cerinic, et al.
Annals of the Rheumatic Diseases|September 19, 2009
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesM C van der Goes, J W G Jacobs, M Boers, et al.
Clinical and Experimental Rheumatology|May 29, 2015
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohortsC Pagnoux, S Carette, N A Khalidi, et al.
Lupus|February 14, 2009
European consensus statement on the terminology used in the management of lupus glomerulonephritisC Gordon, D Jayne, C Pusey, et al.
Pageof 55